Biomedical Engineering Reference
In-Depth Information
91. S. White, D.B. Bennett, S. Cheu, P.W. Conley, D.B. Guzek, S. Gray, J. Howard,
R. Malcolmson, J.M. Parker, P. Roberts, N. Sadrzadeh, J.D. Schumacher,
S. Seshadri, G.W. Sluggett, C.L. Stevenson, N.J. Harper, EXUBERA
®
: Pharma-
ceutical development of a novel product for pulmonary delivery of insulin,
Diabetes Technology & Therapeutics
7 (2005) 896-906.
92. J. Kling, Inhaled insulin's last gasp?
Nat Biotech
26 (2008) 479-480.
93. N. Csaba, M. Garcia-Fuentes, M.J. Alonso, Nanoparticles for nasal vaccination,
Adv. Drug Deliv. Rev.
61 (2009) 140-157.
94. D. Lee, S. Shirley, R. Lockey, S. Mohapatra, Thiolated chitosan nanoparticles
enhance anti-inflammatory effects of intranasally delivered theophylline,
Respiratory Research
7 (2006) 112.
95. T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J.X. Xiao, T. Kissel, Biodegrad-
able nanoparticles for oral delivery of peptides: Is there a role for polymers to
affect mucosal uptake?
European Journal of Pharmaceutics and Biopharmaceutics
50
(2000) 147-160.
96. P. Arora, S. Sharma, S. Garg, Permeability issues in nasal drug delivery,
Drug
Discov. Today
7 (2002) 967-975.
97. A. Vila, H. Gill, O. McCallion, M.J. Alonso, Transport of PLA-PEG particles across
the nasal mucosa: Effect of particle size and PEG coating density,
J. Controlled
Release
98 (2004) 231-244.
98. X. Wang, N. Chi, X. Tang, Preparation of estradiol chitosan nanoparticles for
improving nasal absorption and brain targeting,
European Journal of Pharmaceutics
and Biopharmaceutics
70 (2008) 735-740.
99. X. Gao, W. Tao, W. Lu, Q. Zhang, Y. Zhang, X. Jiang, S. Fu, Lectin-conjugated
PEG-PLA nanoparticles: Preparation and brain delivery after intranasal admin-
istration,
Biomaterials
27 (2006) 3482-3490.
100. A. Mistry, S.Z. Glud, J. Kjems, J. Randel, K.A. Howard, S. Stolnik, L. Illum, Effect
of physicochemical properties on intranasal nanoparticle transit into murine
olfactory epithelium,
J. Drug Target.
17 (2009) 543-552.
101. I. Bravo-Osuna, C. Vauthier, H. Chacun, G. Ponchel, Specific permeability modu-
lation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate)
core-shell nanoparticles,
European Journal of Pharmaceutics and Biopharmaceutics
69 (2008) 436-444.
102. S.C. Corr, C.C.G.M. Gahan, C. Hill, M-cells: Origin, morphology and role in
mucosal immunity and microbial pathogenesis,
FEMS Immunology & Medical
Microbiology
52 (2008) 2-12.
103. P.N. Gupta, K. Khatri, A.K. Goyal, N. Mishra, S.P. Vyas, M-cell targeted biode-
gradable PLGA nanoparticles for oral immunization against hepatitis B,
J. Drug
Target
. 15 (2007) 701-713.
104. M. Garinot, V. Fiévez, V. Pourcelle, F. Stoffelbach, A. des Rieux, L. Plapied, I.
Theate, H. Freichels, C. Jérôme, J. Marchand-Brynaert, Y. Schneider, V. Préat,
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination,
J.
Controlled Release
120 (2007) 195-204.
105. I. Kadiyala, Y. Loo, K. Roy, J. Rice, K.W. Leong, Transport of chitosan-DNA
nanoparticles in human intestinal M-cell model versus normal intestinal entero-
cytes,
European Journal of Pharmaceutical Sciences
39 (2010) 103-109.
106. Y. Sato, Y. Kawashima, H. Takeuchi, H. Yamamoto, In vitro and in vivo evalua-
tion of riboflavin-containing microballoons for a floating controlled drug delivery
system in healthy humans,
Int. J. Pharm.
275 (2004) 97-107.
Search WWH ::
Custom Search